{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T15:40:12Z","timestamp":1758555612924,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,22]]},"DOI":"10.7759\/cureus.92934","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T15:14:59Z","timestamp":1758554099000},"source":"Crossref","is-referenced-by-count":0,"title":["Myopic Control Using Defocus-Incorporated Multiple Segments Spectacle Lenses Plus Low-Concentration Atropine in Patients With Fast Myopia Progression: A Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Chia-Yi","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-Fa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Yao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao Kai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/opo.12686","article-title":"Myopia control 2020: where are we and where are we heading?","volume":"40","author":"Bullimore MA","year":"2020","unstructured":"Bullimore MA, Richdale K. Myopia control 2020: where are we and where are we heading?. Ophthalmic Physiol Opt. 2020, 40:254-70. 10.1111\/opo.12686","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000499","article-title":"A review of current concepts of the etiology and treatment of myopia","volume":"44","author":"Cooper J","year":"2018","unstructured":"Cooper J, Tkatchenko AV. A review of current concepts of the etiology and treatment of myopia. Eye Contact Lens. 2018, 44:231-47. 10.1097\/ICL.0000000000000499","journal-title":"Eye Contact Lens"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)60272-4","article-title":"Myopia","volume":"379","author":"Morgan IG","year":"2012","unstructured":"Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012, 379:1739-48. 10.1016\/s0140-6736(12)60272-4","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-25957","article-title":"IMI - defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies","volume":"60","author":"Flitcroft DI","year":"2019","unstructured":"Flitcroft DI, He M, Jonas JB, et al.. IMI - defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019, 60:M20-30. 10.1167\/iovs.18-25957","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000207","article-title":"Myopia control: a review","volume":"42","author":"Walline JJ","year":"2016","unstructured":"Walline JJ. Myopia control: a review. Eye Contact Lens. 2016, 42:3-8. 10.1097\/ICL.0000000000000207","journal-title":"Eye Contact Lens"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000367","article-title":"Current approaches to myopia control","volume":"28","author":"Leo SW","year":"2017","unstructured":"Leo SW. Current approaches to myopia control. Curr Opin Ophthalmol. 2017, 28:267-75. 10.1097\/ICU.0000000000000367","journal-title":"Curr Opin Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2017.0144","article-title":"A review of myopia control with atropine","volume":"34","author":"Tran HD","year":"2018","unstructured":"Tran HD, Tran YH, Tran TD, Jong M, Coroneo M, Sankaridurg P. A review of myopia control with atropine. J Ocul Pharmacol Ther. 2018, 34:374-9. 10.1089\/jop.2017.0144","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0139-7","article-title":"Update in myopia and treatment strategy of atropine use in myopia control","volume":"33","author":"Wu PC","year":"2019","unstructured":"Wu PC, Chuang MN, Choi J, et al.. Update in myopia and treatment strategy of atropine use in myopia control. Eye (Lond). 2019, 33:3-13. 10.1038\/s41433-018-0139-7","journal-title":"Eye (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1999.15.85","article-title":"Effects of different concentrations of atropine on controlling myopia in myopic children","volume":"15","author":"Shih YF","year":"1999","unstructured":"Shih YF, Chen CH, Chou AC, Ho TC, Lin LL, Hung PT. Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther. 1999, 15:85-90. 10.1089\/jop.1999.15.85","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2020.03.018","article-title":"Overnight orthokeratology","volume":"43","author":"Bullimore MA","year":"2020","unstructured":"Bullimore MA, Johnson LA. Overnight orthokeratology. Cont Lens Anterior Eye. 2020, 43:322-32. 10.1016\/j.clae.2020.03.018","journal-title":"Cont Lens Anterior Eye"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313739","article-title":"Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial","volume":"104","author":"Lam CS","year":"2020","unstructured":"Lam CS, Tang WC, Tse DY, et al.. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020, 104:363-8. 10.1136\/bjophthalmol-2018-313739","journal-title":"Br J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.5.6","article-title":"IMI prevention of myopia and its progression","volume":"62","author":"Jonas JB","year":"2021","unstructured":"Jonas JB, Ang M, Cho P, et al.. IMI prevention of myopia and its progression. Invest Ophthalmol Vis Sci. 2021, 62:6. 10.1167\/iovs.62.5.6","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25599-z","article-title":"Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia","volume":"12","author":"Huang Z","year":"2022","unstructured":"Huang Z, Chen XF, He T, Tang Y, Du CX. Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia. Sci Rep. 2022, 12:22311. 10.1038\/s41598-022-25599-z","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281816","article-title":"A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS\/atropine","volume":"18","author":"Nucci P","year":"2023","unstructured":"Nucci P, Lembo A, Schiavetti I, Shah R, Edgar DF, Evans BJ. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS\/atropine. PLoS One. 2023, 18:e0281816. 10.1371\/journal.pone.0281816","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000360468","article-title":"Myopic traction maculopathy","volume":"54","author":"G\u00f3mez-Resa M","year":"2014","unstructured":"G\u00f3mez-Resa M, Bur\u00e9s-Jelstrup A, Mateo C. Myopic traction maculopathy. Dev Ophthalmol. 2014, 54:204-12. 10.1159\/000360468","journal-title":"Dev Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14205","article-title":"Rhegmatogenous retinal detachment surgery: a review","volume":"51","author":"Warren A","year":"2023","unstructured":"Warren A, Wang DW, Lim JI. Rhegmatogenous retinal detachment surgery: a review. Clin Exp Ophthalmol. 2023, 51:271-9. 10.1111\/ceo.14205","journal-title":"Clin Exp Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12158","article-title":"Progress in understanding the association between high myopia and primary open-angle glaucoma","volume":"42","author":"Ma F","year":"2014","unstructured":"Ma F, Dai J, Sun X. Progress in understanding the association between high myopia and primary open-angle glaucoma. Clin Exp Ophthalmol. 2014, 42:190-7. 10.1111\/ceo.12158","journal-title":"Clin Exp Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/opo.13366","article-title":"High myopia: reviews of myopia control strategies and myopia complications","volume":"44","author":"Shah R","year":"2024","unstructured":"Shah R, Vlasak N, Evans BJ. High myopia: reviews of myopia control strategies and myopia complications. Ophthalmic Physiol Opt. 2024, 44:1248-60. 10.1111\/opo.13366","journal-title":"Ophthalmic Physiol Opt"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165220","article-title":"Treatment of myopia with atropine 0.125% once every night compared with atropine 0.125% every other night: a pilot study","volume":"12","author":"Chen ZR","year":"2023","unstructured":"Chen ZR, Chen SC, Wan TY, et al.. Treatment of myopia with atropine 0.125% once every night compared with atropine 0.125% every other night: a pilot study. J Clin Med. 2023, 12:5220. 10.3390\/jcm12165220","journal-title":"J Clin Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32700-7","article-title":"Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6\u00a0years","volume":"13","author":"Lam CS","year":"2023","unstructured":"Lam CS, Tang WC, Zhang HY, et al.. Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6\u00a0years. Sci Rep. 2023, 13:5475. 10.1038\/s41598-023-32700-7","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91089-7","article-title":"The effect of defocus incorporated multiple segment spectacles' lenses combined with different concentrations atropine for myopia control","volume":"15","author":"Lee CY","year":"2025","unstructured":"Lee CY, Yang SF, Chang YL, Huang JY, Lian IB, Chang CK. The effect of defocus incorporated multiple segment spectacles' lenses combined with different concentrations atropine for myopia control. Sci Rep. 2025, 15:12356. 10.1038\/s41598-025-91089-7","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2024-326852","article-title":"Atropine and spectacle lens combination treatment (aspect): 12-month results of a randomised controlled trial for myopia control using a combination of defocus incorporated multiple segments (DIMS) lenses and 0.025% atropine","volume":"109","author":"Guemes-Villahoz N","year":"2025","unstructured":"Guemes-Villahoz N, Talavero Gonz\u00e1lez P, Porras-\u00c1ngel P, et al.. Atropine and spectacle lens combination treatment (aspect): 12-month results of a randomised controlled trial for myopia control using a combination of defocus incorporated multiple segments (DIMS) lenses and 0.025% atropine. Br J Ophthalmol. 2025, 109:1074-80. 10.1136\/bjo-2024-326852","journal-title":"Br J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.63.1.8","article-title":"Annual incidences and progressions of myopia and high myopia in Chinese schoolchildren based on a 5-year cohort study","volume":"63","author":"Li SM","year":"2022","unstructured":"Li SM, Wei S, Atchison DA, et al.. Annual incidences and progressions of myopia and high myopia in Chinese schoolchildren based on a 5-year cohort study. Invest Ophthalmol Vis Sci. 2022, 63:8. 10.1167\/iovs.63.1.8","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.10.36","article-title":"Myopia progression as a function of sex, age, and ethnicity","volume":"62","author":"Jones-Jordan LA","year":"2021","unstructured":"Jones-Jordan LA, Sinnott LT, Chu RH, et al.. Myopia progression as a function of sex, age, and ethnicity. Invest Ophthalmol Vis Sci. 2021, 62:36. 10.1167\/iovs.62.10.36","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13964","article-title":"Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood","volume":"97","author":"P\u00e4rssinen O","year":"2019","unstructured":"P\u00e4rssinen O, Kauppinen M. Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmol. 2019, 97:510-8. 10.1111\/aos.13964","journal-title":"Acta Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2025.0039","article-title":"Therapeutic effect of topical 0.125% atropine in Korean myopic children: the real-world experience","volume":"39","author":"Kim DH","year":"2025","unstructured":"Kim DH, Han J, Park KA, Yang HK, Kim US, Kim SH, Paik HJ. Therapeutic effect of topical 0.125% atropine in Korean myopic children: the real-world experience. Korean J Ophthalmol. 2025, 39:323-9. 10.3341\/kjo.2025.0039","journal-title":"Korean J Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0297-y","article-title":"Effects of topical atropine on intraocular pressure and myopia progression: a prospective comparative study","volume":"16","author":"Lee CY","year":"2016","unstructured":"Lee CY, Sun CC, Lin YF, Lin KK. Effects of topical atropine on intraocular pressure and myopia progression: a prospective comparative study. BMC Ophthalmol. 2016, 16:114. 10.1186\/s12886-016-0297-y","journal-title":"BMC Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317664","article-title":"Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study","volume":"106","author":"Lam CS","year":"2022","unstructured":"Lam CS, Tang WC, Lee PH, Zhang HY, Qi H, Hasegawa K, To CH. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol. 2022, 106:1110-4. 10.1136\/bjophthalmol-2020-317664","journal-title":"Br J Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-14-40","article-title":"Overnight orthokeratology is comparable with atropine in controlling myopia","volume":"14","author":"Lin HJ","year":"2014","unstructured":"Lin HJ, Wan L, Tsai FJ, Tsai YY, Chen LA, Tsai AL, Huang YC. Overnight orthokeratology is comparable with atropine in controlling myopia. BMC Ophthalmol. 2014, 14:40. 10.1186\/1471-2415-14-40","journal-title":"BMC Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000001410","article-title":"A 3-year randomized clinical trial of MiSight lenses for myopia control","volume":"96","author":"Chamberlain P","year":"2019","unstructured":"Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom Vis Sci. 2019, 96:556-67. 10.1097\/OPX.0000000000001410","journal-title":"Optom Vis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/412442-myopic-control-using-defocus-incorporated-multiple-segments-spectacle-lenses-plus-low-concentration-atropine-in-patients-with-fast-myopia-progression-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T15:15:00Z","timestamp":1758554100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/412442-myopic-control-using-defocus-incorporated-multiple-segments-spectacle-lenses-plus-low-concentration-atropine-in-patients-with-fast-myopia-progression-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.92934","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,22]]}}}